The pursuit of longevity often leads researchers and self-experimenters to rapamycin, yet many fail to realize that sirolimus bioavailability is not a fixed number—it is a moving target dictated by chemical engineering. While the active molecule remains the same, the vehicle delivering it determines whether you achieve life-extending mTOR inhibition or simply expensive, unabsorbed waste.…